Latest filing published 10 Apr 2023 for Biostage, Inc., €343k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
DST Capital LLC appears in our data through filings on Harvard Apparatus Regenerative Technology, Inc. shares, published by SEC (Form 4). Between 17 June 2021 and 6 April 2023, the trades on record add up to 5 filings.
Purchases make up the whole of the open-market record (4 purchases, €1.5M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. 2023 to date brings 1 purchase and no sales.
The median purchase comes to €298k. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 10 April 2023 with an open-market purchase (€343k) in Harvard Apparatus Regenerative Technology, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations